Labcorp stock steadies after earnings beat and guidance reaffirmation

Published on 09/14/2026 at 21:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Labcorp stock closed near USD 311 on the NYSE on September 11, 2026 after recently beating quarterly earnings estimates and reaffirming full-year guidance. Analysts now project about USD 18.32 in EPS for 2026, keeping attention on execution against that range.

Aquarellbild eines gläsernen Bürogebäudes vor Skyline in Pastelltönen — Aquarellmalerei einer Stadtlandschaft mit gläsernem Firmensitz symbolisiert Labcorp, ISIN US50540R4092, im Gesundheitssektor, Illustration mit AI erstellt.

Labcorp Holdings Inc. stock (ISIN US50540R4092) closed at around USD 311 per share on the New York Stock Exchange on September 11, 2026, following a recent single-digit percent move compared with the prior session’s close and stabilizing after an earlier 4.3 percent decline in the shares.Ad-hoc-news reported on September 14, 2026 that the stock traded within its intraday range and remained inside its prevailing 52-week corridor.

Earnings beat and guidance reaffirmation

According to coverage summarized by Ad-hoc-news on September 14, 2026, Labcorp recently reported quarterly earnings per share of USD 4.99 on revenue of USD 3.73 billion, surpassing market expectations and delivering a positive earnings surprise for investors.

The same report notes that Labcorp reaffirmed its adjusted EPS guidance range of USD 18.10 to USD 18.55 for the 2026 financial year, giving investors a clear quantitative framework for assessing performance over the coming quarters.Ad-hoc-news highlights that this guidance reaffirmation came alongside the earnings beat, which tends to strengthen confidence in management’s outlook.

As further context, Ad-hoc-news cites MarketBeat information that analysts now expect Labcorp to deliver about USD 18.32 in EPS for the current year 2026, a point estimate that sits slightly above the midpoint of the company’s adjusted EPS guidance range.

Dividend payment and share-price reaction

The recent period has also been shaped by capital returns to shareholders. As summarized by Ad-hoc-news on September 14, 2026, Labcorp paid a quarterly dividend of USD 0.72 per share on September 11, 2026 to shareholders of record as of August 28, 2026, meaning that the September 11 trading session coincided with the dividend payment date.

Earlier in the recent sequence of sessions, the stock had declined by roughly 4.3 percent before finding support near the current USD 311 region, according to the same coverage referencing MarketBeat commentary.Ad-hoc-news points out that the shares opened at USD 311.36 on September 11, 2026, placing the closing level comfortably above the recent low that followed the 4.3 percent slide, yet still below the highs reached earlier in the 52-week period.

For investors, the combination of a dividend yield component via the USD 0.72 per-share quarterly payout and the reaffirmed full-year EPS guidance provides a blend of income and earnings visibility against which the USD 311 share price level can be evaluated.Ad-hoc-news underscores that the stock remains below recent highs but above recent lows, framing the current level as a consolidation zone after the earnings reaction and dividend date.

Stock level and investor takeaway

Per the recent quote snapshot described by Ad-hoc-news on September 14, 2026, Labcorp stock’s closing level of about USD 311 on September 11, 2026 on the NYSE came against a backdrop in which major US equity indices such as the S&P 500 were advancing, so Labcorp slightly lagged the broader market even as it recovered from the earlier 4.3 percent drop.